Sickle cell disease in Africa: Burden and research priorities

Annals of Tropical Medicine and Parasitology

Volumn 101, Issue 1, 2007, Pages 3-14

  Makani, J ^a   Williams, T N ^a,b,c   Marsh, K ^a,b,c  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTIANDROGEN; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; BETA GLOBIN; CHLOROQUINE; HEMOGLOBIN; HEMOGLOBIN F; HYDROXYUREA; PENICILLIN G; PNEUMOCOCCUS VACCINE; HEMOGLOBIN S;

AFRICA; ALPHA THALASSEMIA; BACTERIAL INFECTION; BACTERIUM; CEREBROVASCULAR ACCIDENT; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; INFECTION; MALARIA; MEDICAL RESEARCH; MORBIDITY; MORTALITY; MUTATION; PAIN; PRIAPISM; PROPHYLAXIS; QUALITY OF LIFE; REVIEW; SICKLE CELL ANEMIA; STROKE; VIRUS INFECTION; CHILD; COMORBIDITY; COST OF ILLNESS; RESEARCH;

BACTERIA (MICROORGANISMS);

AFRICA; ANEMIA, SICKLE CELL; ANTIMALARIALS; BACTERIAL INFECTIONS; CEREBROVASCULAR ACCIDENT; CHILD; COMORBIDITY; COST OF ILLNESS; FETAL HEMOGLOBIN; HEMOGLOBIN, SICKLE; HUMANS; MALARIA; RESEARCH; VIRUS DISEASES;

EID: 33947509031     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485907X154638     Document Type: Review

References (103)

1. Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D., McKie, K., Figueroa, R., Litaker, M., Thompson, W. & Hess, D. (1992). The use of transcranial ultrasonography to predict stroke in sickle cell disease. New England Journal of Medicine, 326, 605-610.
2. Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., Bonds, D. R. & Brambilla, D. (1998). Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. New England Journal of Medicine, 339, 5-11.
3. Adams, R. J., Ohene-Frempong, K. & Wang, W. (2001). Sickle cell and the brain HematoloHematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, Unnumbered, 31-46.
4. Aidoo, M., Terlouw, D. J., Kolczak, M., McElroy, P. D., ter Kuile, F. O., Kariuki, S., Nahlen, B. L., Lal, A. A. & Udhayakumar, V. (2002). Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet, 359, 1311-1312.
5. Aken'ova, Y. A., Bakare, R. A. & Okunade, M. A. (1998). Septicaemia in sickle cell anaemia patients: the Ibadan experience. Central African Journal of Medicine, 44, 102-104.
6. Akinyanju, O. & Johnson, A. O. (1987). Acute illness in Nigerian children with sickle cell anaemia. Annals of Tropical Paediatrics, 7, 181-186.
7. Akuse, R. M. (1996). Variation in the pattern of bacterial infection in patients with sickle cell disease requiring admission. Journal of Tropical Pediatrics, 42, 318-323.
8. Ali, S. A. (1970). Milder variant of sickle-cell disease in Arabs in Kuwait associated with unusually high level of foetal haemoglobin. British Journal of Haematology, 19, 613-619.
9. Allison, A. C. (1954). Protection afforded by sickle-cell trait against subtertian malarial infection. British Medical Journal, i, 290-294.
10. Aluoch, J. R. (1997). Higher resistance to Plasmodium falciparum infection in patients with homozygous sickle cell disease in western Kenya. Tropical Medicine and International Health, 2, 568-571.
11. Amayo, E. O., Owade, J. N., Aluoch, J. R. & Njeru, E. K. (1992). Neurological complications of sickle cell anaemia at KNH: a five year retrospective study. East African Medical Journal, 69, 660-662.
12. Ambe, J. P., Fatunde, J. O. & Sodeinde, O. O. (2001). Associated morbidities in children with sickle-cell anaemia presenting with severe anaemia in a malarious area. Tropical Doctor, 31, 26-27.
13. Angastiniotis, M. & Modell, B. (1998). Global epidemiology of hemoglobin disorders. Annals of the New York Academy of Sciences, 850, 251-269.
14. Athale, U. H. & Chintu, C. (1994). Clinical analysis of mortality in hospitalized Zambian children with sickle cell anaemia. East African Medical Journal, 71, 388-391.
15. Awotua-Efebo, O., Alikor, E. A. & Nkanginieme, K. E. (2004). Malaria parasite density and splenic status by ultrasonography in stable sickle-cell anaemia (HbSS) children. Nigerian Journal of Medicine, 13, 40-43.
16. Berkley, J. A., Lowe, B. S., Mwangi, I., Williams, T., Bauni, E., Mwarumba, S., Ngetsa, C., Slack, M. P., Njenga, S., Hart, C. A., Maitland, K., English, M., Marsh, K. & Scott, J. A. (2005). Bacteremia among children admitted to a rural hospital in Kenya. New England Journal of Medicine, 352, 39-47.
17. Brent, A. J., Ahmed, I., Ndiritu, M., Lewa, P., Ngetsa, C., Lowe, B., Bauni, E., English, M., Berkley, J. A. & Scott, J. A. (2006). Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study. Lancet, 367, 482-488.
18. Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P. & Bonds, D. R. (1995). Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. New England Journal of Medicine, 332, 1317-1322.
19. Claster, S. & Vichinsky, E. P. (2003). Managing sickle cell disease. British Medical Journal, 327, 1151-1155.
20. Corachan, M., Oomen Jr, H. A., Kigadye, F. C. & Morris, H. (1979). Sicklers surviving childhood in Tanzania. Tropical and Geographical Medicine, 31, 531-535.
21. Craddock, P. R. (1973). Bacterial infection in sickle-cell anemia. New England Journal of Medicine, 288, 1301-1302.
22. Daar, S., Hussain, H. M., Gravell, D., Nagel, R. L. & Krishnamoorthy, R. (2000). Genetic epidemiology of HbS in Oman: multicentric origin for the betaS gene. American Journal of Hematology, 64, 39-46.
23. De Ceulaer, K., Higgs, D. R., Weatherall, D. J., Hayes, R. J., Serjeant, B. E. & Serjeant, G. R. (1983). α-Thalassemia reduces the hemolytic rate in homozygous sickle-cell disease. New England Journal of Medicine, 309, 189-190.
24. DeBaun, M. R., Glauser, T. A., Siegel, M., Borders, J. & Lee, B. (1995). Noninvasive central nervous system imaging in sickle cell anemia. A preliminary study comparing transcranial Doppler with magnetic resonance angiography. Journal of Pediatric Hematology/oncology, 17, 29-33.
25. DeBaun, M. R., Schatz, J., Siegel, M. J., Koby, M., Craft, S., Resar, L., Chu, J. Y., Launius, G., Dadash-Zadeh, M., Lee, R. B. & Noetzel, M. (1998). Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology, 50, 1678-1682.
26. Diallo, D. & Tchernia, G. (2002). Sickle cell disease in Africa. Current Opinion in Hematology, 9, 111-116.
27. Earley, C. J., Kittner, S. J., Feeser, B. R., Gardner, J., Epstein, A., Wozniak, M. A., Wityk, R., Stern, B. J., Price, T. R., Macko, R. F., Johnson, C., Sloan, M. A. & Buchholz, D. (1998). Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology, 51, 169-176.
28. Elamin, A. M. (1980). Sickle cell anaemia in adult Zambian Africans. Central African Journal of Medicine, 26, 183-186.
29. Etima, M., Mworozi, E., Christopher, N. & Serjeant, G. R. (2006). Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified? Archives of Disease in Childhood.
30. Falletta, J. M., Woods, G. M., Verter, J. I., Buchanan, G. R., Pegelow, C. H., Iyer, R. V., Miller, S. T., Holbrook, C. T., Kinney, T. R., Vichinsky, E., Becton, D. L., Wang, W., Johnstone, H. S., Wethers, D. L., Reaman, G. H., DeBaun, M. R., Grossman, N. J., Kalinyak, K., Jorgensen, J. H., Bjornson, A., Thomas, M. D. & Reid, C. (1995). Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II. Journal of Pediatrics, 127, 685-690.
31. Fatunde, O. J. & Scott-Emuakpor, A. B. (1992). Foetal haemoglobin in Nigerian children with sickle cell anaemia. Effect on haematological parameters and clinical severity. Tropical and Geographical Medicine, 44, 264-266.
32. Fleming, A. F. (1989). The presentation, management and prevention of crisis in sickle cell disease in Africa. Blood Reviews, 3, 18-28.
33. Fleming, A. F. (1997). HIV and blood transfusion in sub-Saharan Africa. Transfusion Science, 18, 167-179.
34. Friedman, M. J. (1979). Oxidant damage mediates variant red cell resistance to malaria. Nature, 280, 245-247.
35. Gaston, M. H., Verter, J. I., Woods, G., Pegelow, C., Kelleher, J., Presbury, G., Zarkowsky, H., Vichinsky, E., Iyer, R., Lobel, J. S., Diamond, S., Holbrook, C. T., Gill, F. M., Ritchey, K & Falletta, J. M. (1986). Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. New England Journal of Medicine, 314, 1593-1599.
36. Gelpi, A. P. (1973). Migrant populations and the diffusion of the sickle-cell gene. Annals of Internal Medicine, 79, 258-264.
37. Gill, F. M., Sleeper, L. A., Weiner, S. J., Brown, A. K., Bellevue, R., Grover, R., Pegelow, C. H. & Vichinsky, E. (1995). Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood, 86, 776-783.
38. Green, N. S., Fabry, M. E., Kaptue-Noche, L. & Nagel, R. L. (1993). Senegal haplotype is associated with higher HbF than Benin and Cameroon haplo-types in African children with sickle cell anemia. American Journal of Hematology, 44, 145-146.
39. Gumodoka, B., Vos, J., Kigadye, F. C., van Asten, H., Dolmans, W. M. & Borgdorff, M. W. (1993). Blood transfusion practices in Mwanza region, Tanzania. Bugando Medical Centre. AIDS, 7, 387-392.
40. Haghshenass, M., Ismail-Beigi, F., Clegg, J. B. & Weatherall, D. J. (1977). Mild sickle-cell anaemia in Iran associated with high levels of fetal haemoglobin. Journal of Medical Genetics, 14, 168-171.
41. Higgs, D. R., Aldridge, B. E., Lamb, J., Clegg, J. B., Weatherall, D. J., Hayes, R. J., Grandison, Y., Lowrie, Y., Mason, K. P., Serjeant, B. E. & Serjeant, G. R. (1982). The interaction of alpha-thalassemia and homozygous sickle-cell disease. New England Journal of Medicine, 306, 1441-1446.
42. Hill, A. V., Allsopp, C. E., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J. & Greenwood, B. M. (1991). Common West African HLA antigens are associated with protection from severe malaria. Nature, 352, 595-600.
43. Ibidapo, M. O. & Akinyanju, O. O. (2000). Acute sickle cell syndromes in Nigerian adults. Clinical and Laboratory Haematology, 22, 151-155.
44. Izuora, G. I., Kaine, W. N. & Emodi, I. (1989). Neurological disorders in Nigerian children with homozygous sickle cell anaemia. East African Medical Journal, 66, 653-657.
45. John, A. B., Ramlal, A., Jackson, H., Maude, G. H., Sharma, A. W. & Serjeant, G. R. (1984). Prevention of pneumococcal infection in children with homozygous sickle cell disease. British Medical Journal (Clinical Research Edition), 288, 1567-1570.
46. Johnston Jr, R. B., Newman, S. L. & Strath, A. G. (1973). An abnormality of the alternate pathway of complement activation in sickle-cell disease. New England Journal of Medicine, 288, 803-808.
47. Jones, P. H., Pickett, L. C., Anderson, M. J. & Pasvol, G. (1990). Human parvovirus infection in children and severe anaemia seen in an area endemic for malaria. Journal of Tropical Medicine and Hygiene, 93, 67-70.
48. Kan, Y. W. & Dozy, A. M. (1980). Evolution of the hemoglobin S and C genes in world populations. Science, 209, 388-391.
49. Keclard, L., Ollendorf, V., Berchel, C., Loret, H. & Merault, G. (1996). beta S haplotypes, alpha-globin gene status, and hematological data of sickle cell disease patients in Guadeloupe (F.W.I.). Hemoglobin, 20, 63-74.
50. Kinney, T. R., Sleeper, L. A., Wang, W. C., Zimmerman, R. A., Pegelow, C. H., Ohene-Frempong, K., Wethers, D. L., Bello, J. A., Vichinsky, E. P., Moser, F. G., Gallagher, D. M., DeBaun, M. R., Platt, O. S. & Miller, S. T. (1999). Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics, 103, 640-645.
51. Kirkham, F. J., Hewes, D. K., Prengler, M., Wade, A., Lane, R. & Evans, J. P. (2001). Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease. Lancet, 357, 1656-1659.
52. Knox-Macaulay, H. H. (1983). Sickle cell disease in Sierra Leone: a clinical and haematological analysis in older children and adults. Annals of Tropical Medicine and Parasitology, 77, 411-419.
53. Koko, J., Dufillot, D., M'Ba-Meyo, J., Gahouma, D. & Kani, F. (1998). Mortality of children with sickle cell disease in a pediatric department in Central Africa. Archives of Pediatrics, 5, 965-969.
54. Kulozik, A. E., Wainscoat, J. S., Serjeant, G. R., Kar, B. C., Al-Awamy, B., Essan, G. J., Falusi, A. G., Haque, S. K., Hilali, A. M., Kate, S., Ranasinghe, W. A. E. P. & Weatherall, D. J. (1986). Geographical survey of beta S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation. American Journal of Human Genetics, 39, 239-244.
55. Lee, A., Thomas, P., Cupidore, L., Serjeant, B. & Serjeant, G. (1995). Improved survival in homozygous sickle cell disease: lessons from a cohort study. British Medical Journal, 311, 1600-1590.
56. Leikin, S. L., Gallagher, D., Kinney, T. R., Sloane, D., Klug, P. & Rida, W. (1989). Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics, 84, 500-508.
57. Lepage, P., Bogaerts, J., Van Goethem, C., Ntahorutaba, M., Nsengumuremyi, F., Hitimana, D. G., Vandepitte, J., Butzler, J. P. & Levy, J. (1987). Community-acquired bacteraemia in African children. Lancet, i, 1458-1461.
58. Luzzatto, L., Nwachuku-Jarrett, E. S. & Reddy, S. (1970). Increased sickling of parasitised erythrocytes as mechanism of resistance against malaria in the sickle-cell trait. Lancet, i, 319-321.
59. Miller, B. A., Salameh, M., Ahmed, M., Wainscoat, J., Antognetti, G., Orkin, S., Weatherall, D. & Nathan, D. G. (1986). High fetal hemoglobin production in sickle cell anemia in the eastern province of Saudi Arabia is genetically determined. Blood, 67, 1404-1410.
60. Modiano, D., Luoni, G., Sirima, B. S., Simpore, J., Verra, F., Konate, A., Rastrelli, E., Olivieri, A., Calissano, C., Paganotti, G. M., D'Urbano, L., Sanou, I., Sawadogo, A., Modiano, G. & Coluzzi, M. (2001). Haemoglobin C protects against clinical Plasmodium falcipantm malaria. Nature, 414, 305-308.
61. Molineaux, L., Fleming, A. F., Cornille-Brogger, R., Kagan, I. & Storey, J. (1979). Abnormal haemoglobins in the Sudan savanna of Nigeria. III. Malaria, immunoglobulins and antimalarial antibodies in sickle cell disease. Annals of Tropical Medicine and Parasitology, 73, 301-310.
62. Mukherjee, M. B., Surve, R. R., Gangakhedkar, R. R., Ghosh, K., Colah, R. B. & Mohanty, D. (2004). Beta-globin gene cluster haplotypes linked to the betaS gene in western India. Hemoglobin, 28, 157-161.
63. Nagel, R. L. & Labie, D. (1989). DNA haplotypes and the beta s globin gene. Progress in Clinical and Biological Research, 316B, 371-393.
64. Nagel, R. L., Rao, S. K., Dunda-Belkhodja, O., Connolly, M. M., Fabry, M. E., Georges, A., Krishnamoorthy, R. & Labie, D. (1987). The hematologic characteristics of sickle cell anemia bearing the Bantu haplotype: the relationship between G gamma and HbF level. Blood, 69, 1026-1030.
65. Noguchi, C. T., Rodgers, G. P., Serjeant, G. & Schechter, A. N. (1988). Levels of fetal hemoglobin necessary for treatment of sickle cell disease. New England Journal of Medicine, 318, 96-99.
66. Ohene-Frempong, K., Weiner, S. J., Sleeper, L. A., Miller, S. T., Embury, S., Moohr, J. W., Wethers, D. L., Pegelow, C. H. & Gill, F. M. (1998). Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288-294.
67. Ojwang, P. J., Ogada, T., Beris, P., Hattori, Y., Lanclos, K. D., Kutlar, A., Kutlar, F. & Huisman, T. H. (1987). Haplotypes and alpha globin gene analyses in sickle cell anaemia patients from Kenya. British Journal of Haematology, 65, 211-215.
68. Okuonghae, H. O., Nwankwo, M. U. & Offor, E. (1992). Malarial parasitaemia in febrile children with sickle cell anaemia Journal of Tropical Paediatrics, 38, 83-85.
69. Okuonghae, H. O., Nwankwo, M. U. & Offor, E. C. (1993). Pattern of bacteraemia in febrile children with sickle cell anaemia. Annals of Tropical Paediatrics, 13, 55-64.
70. Oner, C., Dimovski, A. J., Olivieri, N. F., Schiliro, G., Codrington, J. F., Fattoum, S., Adekile, A. D., Oner, R., Yuregir, G. T., Altay, C., Gurgey, A., Gupta, R. B., Jogessar, V. B., Kitundu, M. N., Loukopoulos, D., Tamagnini, G. P., Ribeiro, M. L. S., Kutlar, F., Gu, L. H., Lanclos, K. D. & Huisman, T. H. J. (1992). Beta S haplotypes in various world populations. Human Genetics, 89, 99-104.
71. Orjih, A. U. (1999). Malaria parasite metabolism in sickle cells. European Journal of Haematology, 62, 286-292.
72. Orjih, A. U. (2005). Comparison of Plasmodium falciparum growth in sickle cells in low oxygen environment and candle-jar. Acta Tropica, 94, 25-34.
73. Overturf, G. D., Powars, D. & Baraff, L. J. (1977). Bacterial meningitis and septicemia in sickle cell disease. American Journal of Diseases of Children, 131, 784-787.
74. Pasvol, G., Weatherall, D. J. & Wilson, R. J. (1978). Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria. Nature, 274, 701-703.
75. Pasvol, G., Weatherall, D. J., Wilson, R. J., Smith, D. H. & Gilles, H. M. (1976). Fetal haemoglobin and malaria. Lancet, i, 1269-1272.
76. Pearson, H. A., Spencer, R. P. & Cornelius, E. A. (1969). Functional asplenia in sickle-cell anemia. New England Journal of Medicine, 281, 923-926.
77. Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H. & Klug, P. P. (1994). Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine, 330, 1639-1644.
78. Powars, D. R. (1991). Beta s-gene-cluster haplotypes in sickle cell anemia. Clinical and hematologic features. Hematology/oncology Clinics of North America, 5, 475-493.
79. Powars, D. R., Weiss, J. N., Chan, L. S. & Schroeder, W. A. (1984). Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood, 63, 921-926.
80. Powars, D. R., Chan, L. & Schroeder, W. A. (1990). Beta S-gene-cluster haplotypes in sickle cell anemia: clinical implications. American Journal of Pediatric Hematology/oncology, 12, 367-374.
81. Rodgers, G. P., Dover, G. J., Noguchi, C. T., Schechter, A. N. & Nienhuis, A. W. (1990). Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. New England Journal of Medicine, 322, 1037-1045.
82. Rogers, D., Clarke, J., Cupidore, L., Ramlal, A. M., Sparke, B. R. & Serjeant, G. R. (1978). Early deaths in Jamaican children with sickle cell disease. British Medical Journal, i, 1515-1516.
83. Serjeant, G. R., Serjeant, B. E., Thomas, P. W., Anderson, M. J., Patou, G. & Pattison, J. R. (1993). Human parvovirus infection in homozygous sickle cell disease. Lancet, 341, 1237-1240.
84. Smith-Whitley, K., Zhao, H., Hodinka, R. L., Kwiatkowski, J., Cecil, R., Cecil, T., Cnaan, A. & Ohene-Frempong, K. (2004). Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood, 103, 422-427.
85. Steinberg, M. H., Lu, Z. H., Barton, F. B., Terrin, M. L., Charache, S. & Dover, G. J. (1997). Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood, 89, 1078-1088.
86. Stevens, M. C., Hayes, R. J., Vaidya, S. & Serjeant, G. R. (1981). Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhood. Journal of Pediatrics, 98, 37-41.
87. Stockman, J. A., Nigro, M. A., Mishkin, M. M. & Oski, F. A. (1972). Occlusion of large cerebral vessels in sickle-cell anemia. New England Journal of Medicine, 287, 846-849.
88. Teuscher, T., Baillod, B. & Holzer, B. R. (1991). Prevalence of human parvovirus B19 in sickle cell disease and healthy controls. Tropical and Geographical Medicine, 43, 108-110.
89. Thein, S. L. & Craig, J. E. (1998). Genetics of Hb F/F cell variance in adults and heterocellular hereditary persistence of fetal hemoglobin. Hemoglobin, 22, 401-414.
90. Tshilolo, L., Mukendi, R. & Girot, R. (1996). Sickle cell anemia in the south of Zaire. Study of two series of 251 and 340 patients followed-up 1988-1992. Archives of Pediatrics, 3, 104-111 (in French).
91. Veith, R., Galanello, R., Papayannopoulou, T. & Stamatoyannopoulos, G. (1985). Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea. New England Journal of Medicine, 313, 1571-1575.
92. Vichinsky, E. P. (1991). Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Seminars in Hematology, 28, 220-226.
93. Ware, R. E., Steinberg, M. H. & Kinney, T. R. (1995). Hydroxyurea: an alternative to transfusion therapy for stroke in sickle cell anemia. American Journal of Hematology, 50, 140-143.
94. Ware, R. E., Zimmerman, S. A. & Schultz, W. H. (1999). Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood, 94, 3022-3026.
95. Weatherall, D. J. & Clegg, J. B. (2001). Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization, 79, 704-712.
96. Weatherall, D., Hofman, K., Rodgers, G., Ruffin, J. & Hrynkow, S. (2005). A case for developing north-south partnerships for research in sickle cell disease. Blood, 105, 921-923.
97. Williams, T. N., Mwangi, T. W., Wambua, S., Alexander, N. D., Kortok, M., Snow, R. W. & Marsh, K. (2005). Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. Journal of Infectious Diseases, 192, 178-186.
98. Woods, G. M., Jorgensen, J. H., Waclawiw, M. A., Reid, C., Wang, W., Pegelow, C. H., Rogers, Z. R., Iyer, R. V., Holbrook, C. T., Kinney, T. R., Vichinsky, E., DeBaun, M. R., Grossman, N. J., Thomas, M. D. & Falletta, J. M. (1997). Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The Ancillary Nasopharyngeal Culture Study of Prophylactic Penicillin Study II. Journal of Pediatric Hematology/oncology, 19, 327-333.
99. World Bank (1993). World Development Report: Investing in Health. New York, NY: World Bank.
100. World Health Organization (1994). Guidelines for the Control of Haemoglobin Disorders. Document WHO/HDP/HB/GL/94. Geneva: WHO.
101. Yakubu, A. M. & Werblinska, B. (1985). Neurological disturbances in sickle cell disease in children in Zaria, Nigeria. East African Medical Journal, 62, 129-133.
102. Yeats, J., Daley, H. & Hardie, D. (1999). Parvovirus B19 infection does not contribute significantly to severe anaemia in children with malaria in Malawi. European Journal of Haematology, 63, 276-277.
103. Zarkowsky, H. S., Gallagher, D., Gill, F. M., Wang, W. C., Falletta, J. M., Lande, W. M., Levy, P. S., Verter, J. I. & Wethers, D. (1986). Bacteremia in sickle hemoglobinopathies. Journal of Pediatrics, 109, 579-585.